酒精性肝炎microRNA-mRNA差异表达网络的生物信息学分析

张秀芝; 李宁宁; 刘晓丽; 亢春彦; 张进忠

doi:10.3969/j.issn.1001-5256.2019.03.026

酒精性肝炎microRNA-mRNA差异表达网络的生物信息学分析

DOI: 10.3969/j.issn.1001-5256.2019.03.026

1. 河南医学高等专科学校病理教研室
2. 河南省人民医院检验科

基金项目:

河南省科技攻关计划项目(142102310441)；

详细信息

中图分类号: R575.1
计量
- 文章访问数: 259
- HTML全文浏览量: 19
- PDF下载量: 230
- 被引次数: 0
出版历程
- 出版日期: 2019-03-20

A bioinformatics analysis of the microRNA-mRNA differential expression network for alcoholic hepatitis

Department of Pathology, Henan Medical College

Research funding:

摘要

摘要:
目的构建酒精性肝炎（AH）的microRNA-mRNA差异表达网络,寻找AH新的诊疗靶标。方法筛选AH差异表达的microRNA和mRNA;基于TargetScan、DIANA、MIRDB、PICTAR、miRWalk2. 0等软件寻找差异microRNA靶基因,选取差异mRNA中与microRNA变化方向相反的靶基因,构建关键microRNA-mRNA网络;通过注释、可视化和集成发现数据库（DAVID）对相关靶基因进行基因本体论（GO）分析、京都基因与基因组百科全书数据库（KEGG）通路分析;通过GCBI （www. gcbi. com. cn）在线软件对靶基因进行疾病富集分析和核心网络构建;通过Cytoscape软件中GeneMANIA数据库（genemania. org）对关键靶基因进行蛋白相互作用分析,对比3种方法通路分析寻找AH发生过程中的关键通路。结果构建以hsa-mir-21-5p、hsa-mir-148a-3p和hsa-mir-30e-5p等5个差异microRNA及Ⅳ胶原α1链（COL4A1）、血栓反应素2（THBS2）和整合素亚单位α6（ITGA6）等51个靶基因为...
- 肝炎,酒精性 /
- 微RNA /
- RNA,信使 /
- 基因调控网络 /
- 信号传导 /
- 基因疗法
Abstract:
Objective To establish a microRNA-mRNA differential expression network for alcoholic hepatitis ( AH) , and to investigatenew targets for the diagnosis and treatment of AH. Methods Differentially expressed microRNAs and mRNAs between AH patients and nor-mal controls were screened out. Related software including TargetScan, DIANA, MIRDB, PICTAR, and miRWalk 2. 0 was used to searchfor the target genes of differentially expressed microRNA, and a key microRNA-mRNA network was established using the differentially ex-pressed mRNAs that changed in an opposite way to microRNA. The Database for Annotation, Visualization and Integrated Discovery wasused for the gene ontology ( GO) and Kyoto Encyclopedia of Genes and Genome ( KEGG) analyses of target genes. The GCBI online soft-ware ( www. gcbi. com. cn) was used for enrichment analysis of target genes and core network establishment. The GeneMANIA database inCytoscape software ( genemania. org) was used to perform a protein-protein interaction analysis of key target genes. The above three meth-ods were compared in terms of the search for key pathways involved in the development of AH. Results A key microRNA-mRNA networkwas established with 5 differentially expressed microRNAs including hsa-mir-21-5 p, hsa-mir-148 a-3 p, and hsa-mir-30 e-5 pand 51 target genes including collagen type IV alpha 1 chain ( COL4 A1) , thrombospondin-2 ( THBS2) , and integrin alpha 6 ( IGTA6) . Aprotein-protein interaction network of key target genes was established. The GO analysis and various pathway analyses showed that the PI3 K-Akt pathway and local adhesion were closely associated with AH. Conclusion During the development of AH, there are complex interac-tions between the related proteins of key target genes. COL4 A1 and THBS2 may promote the development of AH by activating ITGA6 to regu-late the PI3 K-Akt pathway and the process of local adhesion. The establishment of the microRNA-mRNA network reveals the key links inthe development of AH and highlights the focus of research. The discovery of the genes associated with the PI3 K-Akt pathway in AH is ex-pected to provide new targets for the diagnosis and treatment of AH.
- hepatitis, alcoholic /
- microRNAs /
- RNA, messenger /
- gene regulatory networks /
- signal transduction /
- gene therapy

HTML全文

参考文献(27)

[1] ASHWANI KS, PATRICK SK, GREGORY JG, et al. Alcoholichepatitis:Current challenges and future directions[J]. ClinGastroenterol Hepatol, 2014, 12 (4) :555-564.

[2] PAUL G, YAN Z. Biogenesis of mammalian microRNAs:Aglobal view[J]. Genomics Proteomics Bioinformatics, 2012, 10 (5) :239-245.

[3] ZHAO XM, LIU KQ, ZHU G, et al. Identifying cancer-relatedmicroRNAs based on gene expression data[J]. Bioinformat-ics, 2015, 31 (8) :1226-1234.

[4] GENG YJ, LI SD, LIU ZZ, et al. Inhibitory effect of microRNA-149-5p in the proliferation and migration of HepG2 and Be1-7402 hepatoma cells[J]. J Clin Hepatol, 2017, 33 (6) :1126-1130. (in Chinese) 耿亚军, 李树栋, 刘中政, 等. microRNA-149-5p过表达对肝癌细胞HepG2和Bel-7402增殖及迁移的抑制作用[J].临床肝胆病杂志, 2017, 33 (6) :1126-1130.

[5] BECKER S, FLORIAN A, PATRASCU A, et al. Identification ofcardiomyopathy associated circulating miRNA biomarkers inpatients with muscular dystrophy using a complementary car-diovascular magnetic resonance and plasma profiling ap-proach[J]. J Cardiovasc Magn Reson, 2016, 18 (1) :244.

[6] AGARWAL V, BELL GW, NAM JW, et al. Predicting effectivemicroRNA target sites in mammalian mRNAs[J]. e Life, 2015, 4:e05005.

[7] RECZKO M, MARAGKAKIS M, ALEXIOU P, et al. FunctionalmicroRNA targets in protein coding sequences[J]. Bioinfor-matics, 2012, 28 (6) :771-776.

[8] WONG N, WANG XW. miRDB:An online resource for microR-NA target prediction and functional annotations[J]. NucleicAcids Res, 2015, 43 (D1) :d146-d152.

[9] AZRA K, DOMINIC G, MATTHEW NP, et al. Combinatorial mi-croRNA target predictions[J]. Nat Genet, 2005, 37:495-500.

[10] DWEEP H, STICHT C, PANDEY P, et al. miRWalk-data-base:Prediction of possible miRNA binding sites by"walk-ing"the genes of 3 genome[J]. J Biomed Inform, 2011, 44 (5) :839-847.

[11] DWEEP H, GRETZ N. miRWalk2. 0:A comprehensive atlas ofmicroRNA-target interactions[J]. Nat Methods, 2015, 12 (8) :697-697.

[12] GLYNN D, SHERMAN BT, HOSACK DA, et al. DAVID:Data-base for annotation, visualization, and integrated discovery[J]. Genom Biol, 2003, 4 (5) :p3.

[13] BARRETT T, SUZEK TO, TROUP DB, et al. NCBI GEO:Min-ing millions of expression profiles—database and tools[J].Nucleic Acids Res, 2005, 33:d562-d566.

[14] AFFO S, DOMINGUEZ M, LOZANO JJ, et al. Transcriptomeanalysis identifies TNF superfamily receptors as potential thera-peutic targets in alcoholic hepatitis[J]. Gut, 2013, 62 (3) :452-460.

[15] BLAYA D, COLL M, RODRIGO-TORRES D, et al. IntegrativemicroRNA profiling in alcoholic hepatitis reveals a role for mi-croRNA-182 in liver injury and inflammation[J]. Gut, 2016, 65 (9) :1535-1545.

[16] SMYTH GK. Linear models and empirical Bayes methods forassessing differential expression in microarray experiments[J]. Stat Appl Genet Mol Biol, 2004, 3 (3) :Article3.

[17] RITCHIE ME, PHIPSON B, WU D, et al. Limma powers differ-ential expression analyses for RNA-sequencing and microar-ray studies[J]. Nucleic Acids Res, 2015, 43 (7) :e47.

[18] WANG J, CHU ESH, CHEN HY, et al. microRNA-29b pre-vents liver fibrosis by attenuating hepatic stellate cell activationand inducing apoptosis through targeting PI3K/AKT pathway[J]. Oncotarget, 2015, 6 (9) :7325-7338.

[19] MATHURIN P, BEUZSIN F, LOUVET A, et al. Fibrosis pro-gression occurs in a subgroup of heavy drinkers with typicalhistological features[J]. Aliment Pharmacol Ther, 2007, 25 (9) :1047-1054.

[20] MCKNIGHT-EILY LR, HENLEY SJ, GREEN PP, et al. Alco-hol screening and brief intervention:A potential role in cancerprevention for young adults[J]. Am J Prev Med, 2017, 53 (3S1) :s55-s62.

[21] SCHEIDELER JK, KLEIN WMP. Awareness of the link betweenalcohol consumption and cancer across the world:A review[J]. Cancer Epidemiol Biomarkers Prev, 2018, 27 (4) :429-437.

[22] GU S, NGUYEN BN, RAO S, et al. Alcohol, stem cells andcancer[J]. Genes Cancer, 2017, 8 (9-10) :695-700.

[23] PIANO MR. Alcohol's effects on the cardiovascular system[J]. Alcohol Res, 2017, 38 (2) :219-241.

[24] GOEL S, SHARMA A, GARG A. Effect of alcohol consumption oncardiovascular health[J]. Curr Cardiol Rep, 2018, 20 (4) :19.

[25] REHM J, ROERECKE M. Cardiovascular effects of alcohol con-sumption[J]. Trends Cardiovasc Med, 2017, 27 (8) :534-538.

[26] GHIGO A, LAFFARGUE M, LI M, et al. PI3K and calcium sig-naling in cardiovascular disease[J]. Circ Res, 2017, 121 (3) :282-292.

[27] GHIGO A, MORELLO F, PERINO A, et al. Therapeutic appli-cations of PI3K inhibitors in cardiovascular diseases[J]. Fu-ture Med Chem, 2013, 5 (4) :479-492.

施引文献

资源附件(0)

访问统计